Etiology and natural history of primary sclerosing cholangitis

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 6, Issue 4, 1999, Pages 343-351

  Menon, K V Narayanan ^a   Wiesner, Russell H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cholangiocarcinoma; Primary sclerosing cholangitis

Indexed keywords

DISEASE COURSE; HUMAN; IMMUNOLOGY; MORTALITY; PROGNOSIS; REVIEW; SCLEROSING CHOLANGITIS; SURVIVAL;

CHOLANGITIS, SCLEROSING; DISEASE PROGRESSION; HUMANS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0033250073     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050128     Document Type: Article

References (79)

1. Wiesner RH, LaRusso NF (1980) Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 79:200-206
2. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT (1981) Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology 1:632-640
3. Lee YM, Kaplan MM (1995) Primary sclerosing cholangitis. New Engl J Med 332:924-933
4. Wiesner RH (1994) Current concepts in primary sclerosing cholangitis. Mayo Clin Pro 69:969-982
5. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF (1989) Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10:430-436.
6. Graziadi IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, Hay JE, Gores GJ, Charlton MR, Ludwig J, Poterucha JJ, Steers JL, Krom RAF (1999) Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 29:1050-1056
7. Chapman RW, Arborgh BA, Rhodes JM, Summerfield JA, Dick R, Scheuer PJ, Sherlock S (1980) Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 21:870-877
8. Warren KW, Athanassiades S, Monge JI (1966) Primary sclerosing cholangitis. A study of 42 cases. Am J Surg 111:23-38
9. Palmer KR, Duerden BI, Holdsworth CD (1980) Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery. Gut 21:851-854
10. Dew MJ, van Berge Henegouwen GP, Huybregts AW, Allan RN (1980) Hepatotoxic effect of bile acids in inflammatory bowel disease. Gastroenterology 78:1393-1401
11. Holzbach RT, Marsh ME, Freedman MR, Fazio VW, Lavery I, Jagelman DA (1980) Portal vein bile acids in patients with severe inflammatory bowel disease. Gut 21:428-435
12. Siegel JH, Barnes S, Morris JS (1977) Bile acids in liver disease associated with inflammatory bowel disease. Digestion 15:469-481
13. Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadwick VS, Broom MF (1988) Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenterology 94: 1006-1013
14. Lichtman SN, Sartor RB, Keku J, Schwab JH (1990) Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 98:414-423
15. Cangemi JR, Wiesner RH, Beaver SJ, Ludwig J, MacCarty RL, Dozois RR, Zinsmeister AR, LaRusso NF (1989) Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology 96:790 -794
16. Schrumpf E, Elgjo K, Fausa O, Gjone E, Kolmannskog F, Ritland S (1980) Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 15:689-697
17. Steckman M, Drossman DA, Lesesne HR (1984) Hepatobiliary disease that precedes ulcerative colitis. J Clin Gastroenterol 6:425-428
18. Stockbrugger RW, Olsson R, Jaup B, Jensen J (1988) Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease. Hepatogastroenterology 35:289-294
19. Gross JB Jr, Ludwig J, Wiesner RH, McCall JT, LaRusso NF (1985) Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology 89:272-278
20. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR (1988) Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 95:1036-1042
21. Parashar K, Tarlow MJ, McCrae MA (1992) Experimental reovirus type 3-induced murine biliary tract disease. J Pediatr Surg 27:843-847
22. Richardson SC, Bishop RF, Smith AL (1994) Reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis. J Gastroenterol Hepatol 9:264-268
23. Minuk GY, Rascanin N, Paul RW, Lee PW, Buchan K, Kelly JK (1987) Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 5:8-13
24. Cello JP (1989) Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 86:539-546
25. Martelius T, Krogerus L, Hockerstedt K, Bruggeman C, Lautenschlager I (1998) Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology 27:996-1002
26. Lautenschlager I, Hockerstedt K, Jalanko H, Loginov R, Salmela K, Taskinen E, Ahonen J (1997) Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 25:190-194
27. O'Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey F, Portmann B, Calne RY, Williams R (1988) Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 11:302-305
28. Record CO, Shilkin KB, Eddleston AL, Williams R (1973) Intrahepatic sclerosing cholangitis associated with a familial immunodeficiency syndrome. Lancet 11:18-20
29. Dowsett JF, Miller R, Davidson R, Vaira D, Polydorou A, Cairns SR, Weller IV (1988) Sclerosing cholangitis in acquired immunodeficiency syndrome. Case reports and review of the literature. Scand J Gastroenterol 23:1267-1274
30. Cello JP (1992) Human immunodeficiency virus-associated biliary tract disease. Semin Liver Dis 12:213-218
31. Vakil NB, Schwartz SM, Buggy BP, Brummitt CF, Kherellah M, Letzer DM, Gilson IH, Jones PG (1996) Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. New Engl J Med 334:19-23
32. Waldram R, Kopelman H, Tsantoulas D, Williams R (1975) Chronic pancreatitis, sclerosing cholangitis, and sicca complex in two silings. Lancet 1:550-552
33. Quigley EM, LaRusso NF, Ludwig J, MacSween RN, Birnie GG, Watkinson G (1983) Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 85:1160-1165
34. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann BC, Williams R (1991) Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 13:129-133
35. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S (1983) Association of primary sclerosing cholangitis with HLA-B8. Gut 24:38-41
36. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW (1990) Association of primary sclerosing cholangitis with HLA-DRw52a [see comments]. New Engl J Med 322:1842-1844.
37. Zetterquist H, Broome U, Einarsson K, Olerup O (1992) HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut 33:942-946
38. Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, Eddleston AL, Williams R (1992) Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 16:390-395
39. Olerup O, Olsson R, Hultcrantz R, Broome U (1995) HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis [see comments]. Gastroenterology 108:870-878
40. Bernal W, Moloney M, Underhill J, Donsldson PT (1999) Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 30:237-241
41. Mehal WZ, Lo YM, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, Chapman RW (1994) HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 106:160-167
42. van Milligen de Wit AW, van Deventer SJ, Tytgat GN (1995) Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. Am J Gastroenterol 90:893-900
43. Duerr RH, Targan SR, Landers CJ, LaRusso NF, Lindsay KL, Wiesner RH, Shanahan F (1991) Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 100:1385-1391
44. Snook JA, Chapman RW, Fleming K, Jewell DP (1989) Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 76:30-33
45. Lo SK, Fleming KA, Chapman RW (1992) Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 33:1370-1375
46. Klein R, Eisenburg J, Weber P, Seibold F, Berg PA (1991) Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 14:1147-1152
47. Halbwachs-Mecarelli L, Nusbaum P, Noel LH, Reumaux D, Erlinger S, Grunfeld JP, Lesavre P (1992) Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol 90:79-84
48. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH (1992) Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut 33:657-662
49. Mandal A, Dasgupta A, Jeffers L, Squillante L, Hyder S, Reddy R, Schiff E, Das KM (1994) Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 106:185-192
50. Lo SK, Fleming KA, Chapman RW (1994) A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. J Hepatol 21:974-978
51. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Pena AS, Dolman KM, Bril H, Dekker W, Nauta JJ, Gans ROB, Breed H, Meuwissen SGM (1993) Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A corelation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 34:46-50
52. Gur H, Shen G, Sutjita M, Terrberry J, Alosachie I, Barka N, Lin HC, Peter JB, Meroni PL, Kaplan M, Gershwin E, Shoenfeld Y (1995) Autoantibody profile of primary sclerosing cholangitis. Pathobiology 63:76-82
53. Stoffel MP, Csernok E, Herzberg C, Johnson T, Carroll SF, Gross WL (1996) Antineutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol 104:54-59
54. Lindor KD, Wiesner RH, Katzmann JA, LaRusso NF, Beaver SJ (1987) Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci 32:720-725
55. Snook JA, Chapman RW, Sachdev GK, Heryet A, Kelly PM, Fleming KA, Jewell DP (1989) Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis. J Hepatol 9:36-41
56. Martins EB, Graham AK, Chapman RW, Fleming KA (1996) Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology 23:988-993
57. Broome U, Grunewald J, Scheynius A, Olerup O, Hultcrantz R (1997) Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. J Hepatol 26:527-534
58. Chapman RW, Kelly PM, Heryet A, Jewell DP, Fleming KA (1988) Expression of HLA-DR antigens on bile duct epithelium in primary sclerosing cholangitis. Gut 29:422-427
59. Broome U, Glaumann H, Hultcrantz R, Forsum U (1990) Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis. Scand J Gastroenterol 25:54-58
60. Bloom S, Fleming K, Chapman R (1995) Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut 36:604-609
61. Thomson AW, Satoh S, Nussler AK, Tamura K, Woo J, Gavaler J, van Thiel DH (1994) Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol 95:83-90
62. Adams DH, Mainolfi E, Burra P, Neuberger JM, Ayres R, Elias E, Rothlein R (1992) Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 16:810-814
63. Farrant JM, Hayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, Williams R (1991) Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100:1710-1717
64. Helzberg JH, Petersen JM, Boyer JL (1987) Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 92:1869-1875
65. Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987) Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 22:655-664
66. Dickson ER, Murtaugh PA, Wiesner RH, Grambsch PM, Fleming TR, Ludwig J, LaRusso NF, Malinchoc M, Chapman RW, Kaplan MM, Maddrey WC, Williams R, Farrant M, Langworthy A (1992) Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology 103:1893-1901
67. Porayko MK, Wiesner RH, LaRusso NF, Ludwig J, MacCarty RL, Steiner BL, Twomey CK, Zinsmeister AR (1990) Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease [see comments]. Gastroenterology 98:1594-1602
68. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38:610-615
69. Porayko MK, LaRusso NF, Wiesner RH (1991) Primary sclerosing cholangitis: a progressive disease? Semin Liver Dis 11:18-25
70. Farges O, Malassagne B, Sebagh M, Bismuth H (1995) Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 117:146-155
71. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ Jr, LaRusso NF (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 213:21-25
72. Rosen CB, Nagorney DM (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 11:26-30
73. Marsh JW Jr, Iwatsuki S, Makowka L, Esquivel CO, Gordon RD, Todo S, Tzakis A, Miller C, Van Thiel D, Starzl TE (1988) Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 207:21-25
74. Abu-Elmagd KM, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, Demetris AJ, Krom RA, Van Thiel DH, Starzl TE (1993) Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 177: 335-344
75. Wiesner RH, Porayko MK, Hay JE, LaRusso NF, Steers JL, Krom RA, Dickson ER (1996) Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Liver Transplant Surg 2:99-108
76. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F (1994) Risk factors in primary sclerosing cholangitis. J Hepatol 21:1061-1066
77. Kim WR, Therneau TM, Wiesner RH, Malinchoc M, Kaplan MM, Williams R, Lindor KD, Dickson ER (1997) A revised natural history model for primary sclerosing cholangitis obviates the need for liver histology. Hepatology 26:362A [abstract].
78. Shetty K, Rybicki L, Carey WD (1997) The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 25:1049-1053
79. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, Lake JR, Martin P, McDiarmid SV, Rakela J, Shiffman ML, So SK, Wiesner RH (1997) Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases [see comments]. Liver Transplant Surg 3:628-637